jheinrich@hprd.net

Prior to joining Health Policy R&D, Janet Heinrich directed the public health work at the U.S. General Accounting Office (GAO). At GAO, she directed studies on many topics including oversight of the drug review process at the Food and Drug Administration (FDA), review of human subject protection policies at the National Institutes of Health (NIH) and the FDA, and analysis of vaccine shortages, health care workforce supply, and hospital preparedness for bioterrorism and other emergencies. She was Deputy Director of the National Institute of Nursing Research at NIH. Her work focuses on interactions with the Federal Public Health Service Agencies, such as NIH, the FDA, and the Centers for Disease Control and Prevention (CDC). She also has expertise in issues that involve the Agency for Healthcare Research and Quality (AHRQ), the Centers for Medicare and Medicaid Services (CMS) and works extensively on performance measures and quality of care initiatives in both the public and private sectors. Dr. Heinrich has worked with a variety of public and private organizations, including voluntary home health care agencies and official public health organizations.

EDUCATION

DrPH, Yale University School of Medicine
MPH, Johns Hopkins University
BSN, University of Michigan